Facebook icon Twitter icon Forward icon

New injection guidelines released

New clinical guidance on diabetes injection techniques has been published.

The Forum for Injection Technique UK (FIT) has published the 3rd edition of its Injection Technique Recommendations, featuring contributions from over 65 clinical experts.

FIT UK believes that publishing up-to-date recommendations can help people with diabetes to “achieve the best possible health outcomes by ensuring that the correct dose of medication is delivered to the correct injection site, using the correct technique”. To read more, click here.

Alliance formed to promote diabetes self-management

A new international alliance has been formed with a commitment to bring “wholesale changes” to diabetes self-management.

Leading figures in Type 2 diabetes self-management from across the globe came together at the Leicester Diabetes Centre on Wednesday and Thursday to establish a “vision for patient-centred care”.

Doctors, nurses, researchers and healthcare managers from American, Australia, Qatar, Denmark, Holland, Ireland and the UK attended the ‘Supporting a Therapeutic Patient Alliance for Better Self-Management and Care in Diabetes Summit’. To read more, click here.

Diabetes in care homes guidance published

New guidelines to improve the quality of care for people with diabetes living in care homes have been released.

They provide a series of indicators that can help inspectors to assess whether a service is meeting the particular needs of people with diabetes.

The guidance has been published by the Care Quality Commission (CQC) having been developed in collaboration with Professor Alan Sinclair, from Diabetes Frail, and the JBDS (Joint British Diabetes Societies) Task Group. To read more, click here.

Type 2 study ‘successful’ in real-world practice

Results from a study of people with type 2 diabetes being treated with Forxiga (dapagliflozin) has successfully been replicated in real-world practice, it has been unveiled.

AstraZeneca’s first retrospective observational study using Forxiga (dapagliflozin) to treat people with type 2 diabetes showed a reduction of blood glucose and weight loss reduction. To read more, click here.

Ninjabetic – Fighting for survival...

I’m unsure of how to start this article, so I thought I’d just come out and say it… I’m exhausted. All I’ve thought about for the last few months is how much of a struggle I have found being a patient and I wonder how much longer that will go on for. To read more, click here.